Companies / Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

Nasdaq: IOVACIK 1425205SAN CARLOS, CAiovance.com ↗

Financials · FY2025

Revenue$263.50M
Net income$-390.98M
Total debt—
Cash$110.77M
Diluted EPS$-1.09
Shares outstanding453.0M

Ownership

453.0M shares outstanding · as of Jul 29, 2026
0.23%Insiders
Ownership
Insiders0.23%1,033,915
10%+ / strategic5.40%24,478,268
Institutions59.41%269,099,019
Public float34.96%158,360,230

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Vogt Frederick GCEOInterim CEO & General Counsel · Director
0.12%529,538
Puri Raj K.Chief Regulatory Officer
0.05%239,230
Kirby Daniel GordonChief Commercial Officer
0.03%139,381
Graf Finckenstein FriedrichFormerChief Medical Officer
0.03%131,957
Bilinsky IgorChief Operating Officer
0.03%125,766
Maynard Ryan DDirector
——
Roche Corleen M.Chief Financial Officer
——
Weiser MichaelDirector
——

Institutional holders 272

View all →
HolderValue% of shares
BlackRock, Inc.$153.74M8.16%
State Street Corporation$101.83M5.40%
Mhr Fund Management LLC$101.67M6.39%
Vanguard Group Inc$74.28M6.01%
Two Sigma Investments, LP$48.04M3.02%
Bank of America Corp /De$38.98M3.15%
Millennium Management LLC$33.04M2.08%
Invenomic Capital Management LP$32.65M2.64%
Geode Capital Management, LLC$30.10M1.89%
D. E. Shaw & Co., Inc.$28.14M1.77%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$32.61M+9.3M
+211.22%
13,687,433
3.02% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon stock$30.95M+7.4M
+25.20%
36,957,681
8.16% of shares
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon stock$21.84M+8.0M
+127.38%
14,277,813
3.15% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
AddCommon stock$17.96M+4.3M
+21.41%
24,478,268
5.40% of shares
medium
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
AddCommon stock$14.69M+4.2M
+109.32%
8,016,353
1.77% of shares
medium
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon stock$9.93M+2.8M
+42.95%
9,414,292
2.08% of shares
medium
Q1 2024
as of
Barclays PLC
13F manager
TrimCommon stock$-8.61M-581K
-69.46%
255,353
0.06% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon stock$8.27M+2.4M
2,355,612
0.52% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G—24,478,268—
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—20,161,445—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IOVA——462260100—